Lumora is a successful provider of state-of-the-art molecular diagnostic products into both the clinical and industrial markets. Lumora’s easy to use technology can be employed in fields as diverse as medical diagnostics, agricultural, both for livestock and crops, food safety and pharmaceutical testing, and veterinary and personal care products.
In addition, Lumora has developed novel sample preparation technology which is significantly quicker and easier to operate than traditional methods. The Company is active in developing partnerships with organisations and licensing its technology. Working collaboratively with its chosen partners, Lumora uses its proprietary technology to develop new applications. The Company’s development partners include international biotechnology, clinical diagnostic and industrial microbiology companies.
Through its novel technology, BART (Bioluminescent Assay in Real Time), and its recently developed sample preparation technology, Heat Elution, Lumora has secured a number of significant commercial deals with large international companies including 3M, Promega, Biogal and FIND (Foundation for Innovative Diagnostics).
Lumora's BART technology has been exclusively licensed to 3M for the molecular testing of food, beverages and feed for animals, in its latest innovation, the 3M™ Molecular Detection System. Lumora and Promega have signed a supply agreement for the use of Promega's Ultra-Glo™ luciferase in BART molecular diagnostics technology in the first commercial molecular diagnostic application for Promega's Ultra-Glo luciferase. In addition, Lumora has partnered with FIND to develop a rapid, high-throughput malaria diagnostic assay for screening patients in the developing world. The partnership will allow FIND to access Lumora’s technologies such as BART, and the company’s expertise to develop a novel test that allows rapid screening on a large scale.
Lumora has developed a novel sample preparation technology called Heat Elution (HE). HE has a number of advantages over traditional sample preparation technology, in particular being significantly quicker and easier to operate. In addition to HE, Lumora has a wide range of enabling technologies in areas such as amplification, stem, and other isothermal technologies
Lumora was founded in 2002 by Laurence Tisi and Professor Jim Murray when it was spun-out from the Institute of Biotechnology at the University of Cambridge to exploit unique intellectual property and expertise in bioluminescence.
Lumora’s corporate offices are based in Ely, just outside of Cambridge, England. The Company's investors include; Cambridge Enterprise, (University of Cambridge) Tate Lyle Ventures LP, and Catapult Venture Managers Ltd.